Johnson & Johnson (JNJ) Q2 2024 Earnings
Johnson & Johnson reported Q2 2024 revenue of $22.4B, beat analyst consensus of $22.3B by $116.6M. Diluted EPS came in at $2.82, beat the $2.71 consensus by $0.11. Johnson & Johnson reports across 2 business segments, led by Innovative Medicine and MedTech.
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Johnson & Johnson's Q2 2024 earnings report.
Johnson & Johnson (JNJ) reported Q2 2024 earnings on July 17, 2024 before market open.
Johnson & Johnson reported revenue of $22.4B and diluted EPS of $2.82 for Q2 2024.
Revenue beat the consensus estimate of $22.3B by $116.6M. EPS beat the consensus estimate of $2.71 by $0.11.
You can read the 8-K earnings release (0000200406-24-000071) and the 10-Q periodic report (0000200406-24-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.